X0508 4 2023-10-16 0 0001601830 RECURSION PHARMACEUTICALS, INC. RXRX 0001856081 Virani Shafique C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101 0 1 0 0 Chief Business Officer 1 Class A Common Stock 2023-10-16 4 M 0 18000 2.22 A 158351 D Class A Common Stock 2023-10-16 4 S 0 18000 6.30 D 140351 D Stock Option (Right to Buy) 8.55 2033-02-01 Class A Common Stock 0 212507 D Stock Option (Right to Buy) 2.22 2023-10-16 4 M 0 18000 0.00 D 2030-03-03 Class A Common Stock 18000 415469 D Stock Option (Right to Buy) 11.40 2032-02-04 Class A Common Stock 0 80450 D Stock Option (Right to Buy) 11.40 2022-02-04 2032-02-04 Class A Common Stock 0 5436 D Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. 704,955 shares were originally subject to this stock option upon the grant date. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. /s/ Jonathan Golightly, attorney-in-fact 2023-10-18